Management of small bowel Crohn disease

Problems in General Surgery

Volumn 16, Issue 2, 1999, Pages 58-67

  Hurst, Roger D ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; IMMUNOMODULATING AGENT; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; SALAZOSULFAPYRIDINE;

CROHN DISEASE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTESTINE FISTULA; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; INTESTINE RESECTION; PRIORITY JOURNAL; REVIEW; SMALL INTESTINE DISEASE; SURGICAL TECHNIQUE; SYMPTOMATOLOGY; TREATMENT INDICATION;

EID: 0033050322     PISSN: 07398328     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Michelassi F, Balestracci T, Chappell R, Block GE. Primary and recurrent Crohn's disease: experience with 1397 patients. Ann Surg 1991;214:230-6.
2. Sachar DB, Andrews HA, Farmer RG, et al. Proposed classification of patients subgroups in Crohn's disease. Gastroenterol Int 1992;5:141-54.
3. Farmer RG, Hawk WA, Turnbull RB. Indications for surgery in Crohn's disease: analysis of 500 cases. Gastroenterology 1976;71:245-50.
4. Rutgeerts P, Vantrappen G, Geboes K. Endoscopy in inflammatory bowel disease. Scand J Gastroent 1989; 170:12-9.
5. Rankin GB, Watts HD, Melnyk CS, Kelley ML. National cooperative Crohn's disease study: extraintestinal manifestations and perianal complications. Gastroenterology 1979;77:914-20.
6. Bjarnason I, Peters TJ. Intestinal permeability, nonsteroidal anti-inflammatory drug enteropathy and inflammatory bowel disease: an overview. Gut 1989; 30(Festschrift):22-8.
7. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med 1997;337:1029-35.
8. Jaffe BM, Hooker RL, Rabinowitz S. Short bowel syndrome. In: Scott WH, Sawyers JL, eds. Surgery of the stomach, duodenum and small intestine. 2nd ed. Boston: Blackwell Scientific, 1992:812-33.
9. D'Haens GR, Rutgeerts P. Medical therapy for Crohn's disease. Curr Opin Gastroenterol 1998;14: 306-11.
10. Hurst RD, Molinari M, Chung TP, Rubin M, Michelassi F. Prospective study of the features, indications and surgical treatment in 513 consecutive patients affected by Crohn's disease. Surgery 1997;122:661-8.
11. Block GE, Michelassi F, Tanaka M, Riddell RH, Hanauer SB. Crohn's disease. Curr Probl Surg 1993; 2:173-272.
12. Oliveria L, Wexner SD, Daniel N, et al. Mechanical bowel preparation for elective colorectal surgery. Dis Colon Rectum 1977;40:585-91.
13. Kaiser AB. Antibiotic prophylaxis in surgery. N Engl J Med 1996;315:1129-38.
14. Hulten L. Surgical management and strategy in classical Crohn's disease. Int Surg 1992;77:2-8.
15. Garlock JH, Crohn BB. An appraisal of the results of surgery in treatment of regional ileitis. JAMA 1945; 127:205-8.
16. Atwell JD, Duthie HL, Goligher JC. The outcome of Crohn's disease. Br J Surg 1965;52:966-72.
17. Fazio VW, Marchetti F, Church J, et al. Effect of resection margins on the recurrence of Crohn's disease in the small bowel: a randomized controlled trial. Ann Surg 1996;224:563-73.
18. Hurst RD, Michelassi F. Strictureplasty for Crohn's disease: techniques and long-term results. World J Surg 1998;22:359-63.
19. Michelassi F. Side-to-side Isoperistaltic stricturoplasty for multiple Crohn's strictures. Dis Colon Rectum 1996;39:345-9.
20. Fasth S, Hellberg R, Hulten L, Magnusson O. Early complications after surgical treatment for Crohn's disease with particular reference for factors affecting their development. Acta Chir Scand 1980;146:519-26.
21. Fazio VW, Tjandra JJ, Lavery IC, Church JM, Milsom JW, Oakley JR. Long-term follow-up of strictureplasty in Crohn's disease. Dis Colon Rectum 1993;36: 355-61.
22. Spencer MP, Nelson H, Wolff BG, Dozois RR. Strictureplasty for obstructive Crohn's disease: the Mayo experience. Mayo Clin Proc 1994;69:33-6.
23. Ozuner G, Fazio VW, Lavery IC, Church JM, Hull TL. How safe is strictureplasty in the management of Crohn's disease? Am J Surg 1996;171:57-61.
24. Schraut WH, Block GE. Enterovesical fistula complicating Crohn's ileocolitis. Am J Gastroenterol 1984; 79:186-90.
25. Michelassi F, Stella M, Balestracci T, Giuliante F, Marogna P, Block GE. Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn's disease. Ann Surg 1993;218:660-6.
26. Young-Fadok TM, Wolff BG, Meagher A, Benn PL, Dozois RR. Surgical management of ileosigmoid fistulas in Crohn's disease. Dis Colon Rectum 1997;40: 558-61.
27. Schraut WH, Chapman C, Abraham VS. Operative treatment of Crohn's ileocolitis complicated by ileosigmoid and ileovesical fistulae. Ann Surg 1988;207:48-51.
28. Novotny DA, Rubin RJ, Slezak FA, Porter JA. Arterial thromboembolic complications of inflammatory bowel disease: report of three cases. Dis Colon Rectum 1992;35:193.
29. Wester E. The management of patients after small bowel resection. Gastroenterology 1976:;71:146.
30. Tjandra JJ, Fazio VW. Strictureplasty for ileocolic anastomotic strictures in Crohn's disease. Dis Colon Rectum 1993;36:1099-104.
31. McLeod RS, Wolff BG, Steinhart AH, et al. Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 1995; 109:404-13.
32. Korelitz B, Hanauer SB, Rutgeerts P, Present DH, Pepercom M. Post-operative prophylaxis with 6-MP, 5-ASA, or placebo in Crohn's disease: a 2 year multicenter trial [abstract]. Gastroenterology 1998;114: A1011.
33. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994;106:643-8.
34. Kaufman HJ, Taubin HL. Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. Ann Int Med 1987;107:513-6.